Article Text

Download PDFPDF
Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours
  1. N Scott1,
  2. E Millward1,
  3. E J Cartwright2,
  4. S R Preston3,
  5. P L Coletta2
  1. 1Department of Pathology, St James’s University Hospital, United Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK
  2. 2Department of Molecular Medicine, St James’s University Hospital
  3. 3Department of Surgery, St James’s University Hospital
  1. Correspondence to:
 Dr N Scott
 Department of Pathology, St James’s University Hospital, Leeds LS9 7TF, UK; nigelscott50hotmail.com

Abstract

Aims: To establish whether gastrin releasing peptide (GRP) and the GRP receptor (GRPR) are expressed together in gastrointestinal carcinoid tumours.

Methods: Twenty six carcinoid tumours from the stomach, small intestine, appendix, and colorectum were investigated by immunohistochemistry for GRP and GRPR.

Results: GRP was detected in nine of 19 tumours and GRPR in 22 of 26. Coexpression of both the ligand and receptor was seen in six of 19 cases. GRPR but not GRP was more strongly expressed in appendix and colonic tumours.

Conclusions: GRP and GRPR are produced by a large number of gastrointestinal carcinoid tumours. An autocrine/paracrine pathway may exist for GRP stimulated cell proliferation in some of these neoplasms, analogous to that seen in small cell anaplastic carcinoma of the lung.

  • gastrin releasing peptide
  • gastrin releasing peptide receptor
  • immunohistochemistry
  • carcinoid
  • gastrointestinal
  • GRP, gastrin releasing peptide
  • GRPR, gastrin releasing peptide receptor

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes